Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1V64
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $56,403
Award facts
- Contract value 100% obligated
- $56,403.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $56.4K firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors on January 16, 2026, with completion scheduled for January 20, 2026. This non-competitive delivery order was placed against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9M through December 2026. The contract specifies performance at the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its primary operations as a major pharmaceutical distributor serving federal medical procurement needs.
AmerisourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), which holds the underlying $999.9M IDC with DLA. Dupixent is a specialty biologic medication prescribed for various inflammatory conditions including atopic dermatitis, asthma, and eosinophilic disorders, representing critical pharmaceutical inventory for military healthcare systems and veteran treatment facilities supported through the DLA Medical Supply Chain. The award reflects the company's established capability to efficiently fulfill government contracts for specialty pharmaceuticals and essential medical commodities required across Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F1V64?
SPE2DR26F1V64 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F1V64 worth?
The government has obligated $56,403 on SPE2DR26F1V64.
Is contract SPE2DR26F1V64 an order under another contract?
Yes. SPE2DR26F1V64 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1V64 competed?
The extent of competition for SPE2DR26F1V64 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award